entertainment -WSS

entertainment

author：explore 2025-09-06 04:33:59 - browse：775

Sammy Kimball for STAT

Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally time for Novavax to shine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of prescription drug pricing. Then, STAT’s Helen Branswell calls in to walk us through a news-packed week for vaccines, including weighty decisions for Covid-19 and RSV.

For more on what we cover, here’s the story on conflicts of interest; here’s the latest on RSV vaccines; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： Addressing health care workers' trauma can help fight burnout

hotspot

WSS

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Investigation reveals sickle cell patients pressured into sterilizations

Apple Vision Pro: A first look at health apps on the new VR headset

The real point of Kenneth Smith’s execution by nitrogen gas

Digital health: a case of mistaken identity

New Ultima Genomics DNA sequencer can read genome for $100

focus

entertainment

Wikipedia

At least 13 dead in Texas as scorching temps continue

H5N1 virus can be tracked in retail milk, scientists say

BioMarin wins approval for gene therapy to treat hemophilia A

Biogen joins immunology wave with $1.15 billion acquisition of HI

Tori Bowie and the unacceptable rates of Black maternal death

Vertigo drug brings hope for rare neuron disorder, Niemann

Wildfire smoke exposes gaps in outdoor worker protections

Congressmen charge Covid hearing ‘could have been an email’

Medicare details structure of new drug price negotiation program

Making the case for fair compensation in clinical trials

focus

Apple Vision Pro: A first look at health apps on the new VR headset

FDA poised to publish guidelines for clinical trial diversity

Questions and answers about ramping up H5N1 bird flu vaccine

FDA poised to publish guidelines for clinical trial diversity

Biogen joins immunology wave with $1.15 billion acquisition of HI

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Wikipedia

hotspot

hotspot

hotspot